Published Date:2025-06-10 Original Link:https://www.onenessbio.com/en/news_detail362_1.htm No 1 Date of announcement 2025/06/10 Time of announcement 21:04:29 Subject Mechanism of ON101 cream for prevention and treatment of radiation dermatitis has been published in the SCI journal, Life Sciences To which item it meets Subparagraph 53 Date of events 2025/06/10 Statement 1.Date of occurrence of the event:2025/06/10 2.Company name:ONENESS...Read More
Published Date:2025-05-22 Original Link:https://www.onenessbio.com/en/news_detail360_1.htm No 1 Date of announcement 2025/05/22 Time of announcement 06:40:05 Subject The cost-saving benefits of Fespixon in Singapore’s healthcare setting has been published in the SCI journal Diabetes, Obesity and Metabolism. To which item it meets Subparagraph 53 Date of events 2025/05/21 Statement 1.Date of occurrence of the event:2025/05/21 2.Company name:ONENESS...Read More
Published Date:2025-05-21 Original Link:https://www.onenessbio.com/en/news_detail359_1.htm No 1 Date of announcement 2025/05/21 Time of announcement 20:42:12 Subject Bonvadis topical cream received medical device marketing authorization approval for all indications in wounds for Australia. To which item it meets Subparagraph 10 Date of events 2025/05/21 Statement 1. Date of occurrence of the event: 2025/05/21 2. New drug name...Read More
Published Date:2025-05-16 Original Link:https://www.onenessbio.com/en/news_detail358_1.htm No 1 Date of announcement 2025/05/16 Time of announcement 16:39:51 Subject Oneness Biotech Co., Ltd. receives an United Arab Emirates patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2025/05/16 Statement Date of occurrence of the...Read More
Published Date:2025-05-12 Original Link:https://www.onenessbio.com/en/news_detail357_1.htm No 1 Date of announcement 2025/05/12 Time of announcement 16:20:01 Subject The Company’s 2025Q1 consolidated financial statements have been approved by the Board of Directors To which item it meets paragraph 31 Date of events 2025/05/12 Statement Date of the board of directors submitted or approved: 2025/05/12 Date of the audit...Read More
Published Date:2025-05-09 Original Link:https://www.onenessbio.com/en/news_detail356_2.htm No 1 Date of announcement 2025/05/09 Time of announcement 16:15:39 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by India CDSCO. To which item it meets Subparagraph 10 Date of events 2025/05/09 Statement 1. Date of occurrence of the event:2025/05/09 2. New drug...Read More
Published Date:2025-04-23 Original Link:https://www.onenessbio.com/en/news_detail354_2.htm No 1 Date of announcement 2025/04/23 Time of announcement 17:46:40 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by Egypt EDA. To which item it meets Subparagraph 10 Date of events 2025/04/23 Statement 1. Date of occurrence of the event:2025/04/23 2. New drug...Read More
Published Date:2025-04-21 Original Link:https://www.onenessbio.com/en/news_detail347_2.htm No 1 Date of announcement 2025/04/21 Time of announcement 16:50:20 Subject Oneness announces information about the first investor conference in 2025. To which item it meets paragraph 12 Date of events 2025/04/28 Statement Date of institutional investor conference: 2025/04/28 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor conference:...Read More
Published Date:2025-04-16 Original Link:https://www.onenessbio.com/en/news_detail353_2.htm No 1 Date of announcement 2025/04/16 Time of announcement 22:02:17 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Australia TGA. To which item it meets Subparagraph 10 Date of events 2025/04/16 Statement 1. Date of occurrence of the event:2025/04/16 2. New drug...Read More
